The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics (Q46878607)
Jump to navigation
Jump to search
scientific article published on 14 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics |
scientific article published on 14 November 2007 |
Statements
1 reference
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics (English)
1 reference
S V Vormfelde
1 reference
M R Toliat
1 reference
M Schirmer
1 reference
I Meineke
1 reference
P Nürnberg
1 reference
J Brockmöller
1 reference
14 November 2007
1 reference
83
1 reference
6
1 reference
815-817
1 reference
Identifiers
1 reference
1 reference